Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / Common Stock, $0.0001 par value
-
Shares outstanding
-
92,448,158
-
Total 13F shares
-
10,815,342
-
Share change
-
-535,681
-
Total reported value
-
$29,741,148
-
Put/Call ratio
-
14%
-
Price per share
-
$2.75
-
Number of holders
-
48
-
Value change
-
-$1,571,507
-
Number of buys
-
24
-
Number of sells
-
21
Institutional Holders of Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value (VRCA) as of Q4 2022
As of 31 Dec 2022,
Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value (VRCA) was held by
48 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
10,815,342 shares.
The largest 10 holders included
PERCEPTIVE ADVISORS LLC, FMR LLC, BML Capital Management, LLC, VANGUARD GROUP INC, MILLENNIUM MANAGEMENT LLC, GEODE CAPITAL MANAGEMENT, LLC, RENAISSANCE TECHNOLOGIES LLC, Steel Peak Wealth Management LLC, KORNITZER CAPITAL MANAGEMENT INC /KS, and CONNING INC..
This page lists
48
institutional shareholders reporting positions in this security
for the Q4 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.